Literature DB >> 16938568

Translocation (10;11)(p12;q23) in childhood acute myeloid leukemia: incidence and complex mechanism.

Irina Stasevich1, Regina Utskevich, Anatoly Kustanovich, Natallia Litvinko, Tatsiana Savitskaya, Svetlana Chernyavskaya, Olga Saharova, Olga Aleinikova.   

Abstract

Using both conventional and molecular cytogenetic methods, we found five new cases of t(10;11)(p12;q23). This translocation represented 28% of all cases of childhood AML treated at our center in 2004, and 63% of AML with rearrangements of 11q23. We describe three mechanisms for the translocation. Different fragments of 11q were involved in four of the five cases. One patient showed a cytogenetically cryptic insertion of 5' part of MLL into the 3' part of MLLT10 in 10p12. The median event-free survival of patients was 8.1 months, and we conclude that the t(10;11)(p12;q23) is associated with unfavorable prognosis in childhood acute myeloid leukemia.

Entities:  

Mesh:

Year:  2006        PMID: 16938568     DOI: 10.1016/j.cancergencyto.2006.03.011

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Identification of Mixed Lineage Leukemia Gene (MLL)/MLLT10 Fusion Transcripts by Reverse Transcription-PCR and Sequencing in a Case of AML With a FISH-Negative Cryptic MLL Rearrangement.

Authors:  Kiwoong Ko; Min-Jung Kwon; Hee-Yeon Woo; Hyosoon Park; Chang-Hun Park; Seung-Tae Lee; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2015-05-21       Impact factor: 3.464

2.  A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML.

Authors:  Bo-Rui Chen; Anagha Deshpande; Karina Barbosa; Maria Kleppe; Xue Lei; Narayana Yeddula; Pablo Sánchez Vela; Alexandre Rosa Campos; Robert J Wechsler-Reya; Anindya Bagchi; Soheil Meshinchi; Connie Eaves; Irmela Jeremias; Torsten Haferlach; David A Frank; Ze'ev Ronai; Sumit Chanda; Scott A Armstrong; Peter D Adams; Ross L Levine; Aniruddha J Deshpande
Journal:  Blood       Date:  2021-06-17       Impact factor: 25.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.